28th Jul 2021 22:00
Scancell Holdings PLC - Oxford, England-based developer of immunotherapies for treatment of cancer and infectious disease - Appoints Founder, Board Director and Chief Scientific Officer Lindy Durrant as chief executive officer with immediate effect.
Durrant was previously co-CEO, but stepped down to chief scientific officer in 2016.
Cliff Holloway decides to step down as a board director and CEO, also with immediate effect.
Durrant says: "I believe Scancell has an unrivalled pipeline of products and I, along with the rest of the team at Scancell, intend to continue to drive our pipeline through the clinic as we focus on accelerating the development of what we believe to be our most commercially promising assets."
Current stock price: EUR19.60 pence
Year-to-date change: up 40%
By Paul McGowan; [email protected]
Copyright 2021 Alliance News Limited. All Rights Reserved.
Related Shares:
Scancell Holdings